Humanigen, Inc. / Fundamentals

    Income statement

    Net revenue
    €1.46M
    Cost of goods sold
    €0.00
    Gross profit
    €1.46M
    SG&A expenses
    €12.85M
    R&D expenses
    €33.23M
    EBITDA
    -€44.13M
    D&A
    €495.92K
    EBIT
    -€44.62M
    Interest expenses
    €1.89M
    EBT
    -€46.02M
    Tax expenses
    -€426.43K
    Net income
    -€45.73M

    Cash flow statement

    Net deferred tax
    €0.00
    Non-cash items
    -€160.45K
    Changes in working capital
    -€13.71M
    Operating cash flow
    -€55.18M
    Capex
    €0.00
    Other investing cash flow
    €0.00
    Net investing cash flow
    €0.00
    Total cash dividends paid
    €0.00
    Issuance of common stock
    €38.88M
    Debt repayment
    €0.00
    Other financing cash flow
    €17.15M
    Net financing cash flow
    €17.43M
    Foreign exchange effects
    €0.00
    Net change in cash
    -€56.50M
    Cash at end of period
    €2.66M
    Free cash flow
    -€55.18M

    Balance sheet

    Cash and cash equivalents
    €2.66M
    Cash and short-term investments
    €2.66M
    Total receivables
    €0.00
    Inventory
    €0.00
    Other current assets
    €1.66M
    Total current assets
    €4.31M
    Property, plant & equipment
    €0.00
    Goodwill
    €0.00
    Intangible assets
    €0.00
    Long-term investments
    €0.00
    Other non-current assets
    €77.22K
    Total non-current assets
    €77.22K
    Total assets
    €4.39M
    Accounts payable
    €32.94M
    Short-term debt
    €0.00
    Other current liabilities
    €12.03M
    Total current liabilities
    €45.73M
    Long-term debt
    €0.00
    Deferred tax liabilities
    €0.00
    Other non-current liabilities
    €0.00
    Total non-current liabilities
    €1.33M
    Total liabilities
    €47.05M
    Common stock
    €102.10K
    Retained earnings
    -€588.58M
    Other equity
    €0.00
    Total equity
    -€42.66M
    Total liabilities and shareholders' equity
    €4.39M

    Company information

    Market capitalization
    €0.00
    Employees
    6
    Enterprise Value
    -€10.16M

    Company ratios

    Gross margin
    100.0% Much better than peer group: -1,471,141,633,263,961,800.0%
    EBITDA margin
    -3,027.2% Much worse than peer group: 495,921,798,206,249,200,000.0%
    EBIT margin
    -3,061.2% Much worse than peer group: 504,448,484,699,037,400,000.0%
    EBT margin
    -3,156.8% Much worse than peer group: 502,307,803,118,414,700,000.0%
    Net margin
    -3,137.3% Much worse than peer group: 499,597,439,317,409,800,000.0%
    ROE
    107.2% Much worse than peer group: 527.2%
    ROA
    -1,041.9% Much worse than peer group: -263.6%
    Asset turnover
    33.2% Better than peer group: 23.4%
    FCF margin
    -3,785.5% Much worse than peer group: 446,814,179,164,952,930,000.0%
    FCF yield
    0.0%
    Efficiency ratio
    3,127.2%
    Net sales per employee
    €242.96K
    Net income per employee
    -€7.62M

    Notifications